Cyclacel Pharmaceuticals Files 8-K with Corporate Updates
Ticker: BGMSP · Form: 8-K · Filed: Jul 2, 2025 · CIK: 1130166
Sentiment: neutral
Topics: corporate-governance, filing-update
Related Tickers: CYCC
TL;DR
Cyclacel filed an 8-K on 7/2/25 for corporate changes and disclosures. No financial details yet.
AI Summary
Cyclacel Pharmaceuticals, Inc. filed an 8-K on July 2, 2025, reporting amendments to its Articles of Incorporation or Bylaws, a Regulation FD disclosure, and financial statements/exhibits. The company, formerly Xcyte Therapies Inc., is incorporated in Delaware and has its fiscal year end on December 31st. The filing does not contain specific financial figures or details about the nature of the amendments or disclosures.
Why It Matters
This filing indicates corporate housekeeping and potential regulatory disclosures for Cyclacel Pharmaceuticals, Inc., which could impact investor understanding of the company's structure and compliance.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain information that directly impacts the company's financial health or operational risk.
Key Players & Entities
- Cyclacel Pharmaceuticals, Inc. (company) — Registrant
- XCYTE THERAPIES INC (company) — Former company name
- July 2, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
FAQ
What specific amendments were made to Cyclacel Pharmaceuticals, Inc.'s Articles of Incorporation or Bylaws?
The filing does not specify the exact nature of the amendments made to the Articles of Incorporation or Bylaws.
What is the subject of the Regulation FD disclosure in this 8-K filing?
The filing mentions a Regulation FD disclosure but does not provide details on its content.
Are there any specific financial statements or exhibits included with this 8-K filing?
The filing indicates that Financial Statements and Exhibits are included, but their specific content is not detailed in the provided text.
When is Cyclacel Pharmaceuticals, Inc.'s fiscal year end?
Cyclacel Pharmaceuticals, Inc.'s fiscal year end is December 31st.
What was the former name of Cyclacel Pharmaceuticals, Inc. and when did the name change occur?
The former name of Cyclacel Pharmaceuticals, Inc. was XCYTE THERAPIES INC, and the date of the name change was December 18, 2000.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 2, 2025 regarding Cyclacel Pharmaceuticals, Inc. (BGMSP).